Allegheny Health Network
Find a
Doctor
Request An Appointment Login to
MyChart
Patient
Center
News Classes &
Events
Contact
Us
Call 412.Doctors

Active Clinical Trials

Quantification of Heart Failure using Short-wave Infrared Imaging

Active
Allegheny General Hospital
Allegheny General Hospital

Sponsor: 
ChemImage Corporation
Contact: 

For more information, please contact Jessica Burkardt at 724-226-7460 or Jessica.Burkardt@ahn.org.

Quantification of Heart Failure using Short-wave Infrared Imaging

Purpose: 

The research objective is to determine if measurements made by short-wave infrared (SWIR) instruments can safely and non-invasively determine the degree of peripheral edema in patients with HF.

Cohort 2, Inclusion Criteria: 1) Males or females age 18 to 90 years. 2) Evidence from history, physical examination, imaging studies and laboratory tests that support the diagnosis of HF. Cohort 3, Inclusion Criteria: 1) Males or females age 18 to 90 years. 2) Evidence from history, physical examination, imaging studies and laboratory tests that support the diagnosis of HF.

Cohort 2, Exclusion Criteria 1) Subjects whose clinical care could be compromised by the SWIR evaluation. 2) Subjects who are incapable of providing informed consent. 3) Subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures. 4) Subjects with overt skin lesions (to include healed incisions, or active wounds) or obscuring tattoos on their anterior shin. 5) Subjects who have a confirmed or suspected pregnancy. Subjects will be asked to self-report to the study doctor. 6) Subjects with peripheral edema caused by conditions unrelated to HF. 7) Patients with a history of deep vein thrombosis 8) Patients with a history of lymphedema Cohort 3, Exclusion Criteria 1) Subjects whose clinical care could be compromised by the SWIR evaluation. 2) Subjects who are incapable of providing informed consent. 3) Subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures. 4) Subjects with overt skin lesions (to include healed incisions, or active wounds) or obscuring tattoos on their anterior shin. 5) Subjects who have a confirmed or suspected pregnancy. Subjects will be asked to self-report to the study doctor. 6) Subjects with peripheral edema caused by conditions unrelated to HF. 7) Patients with a history of deep vein thrombosis 8) Patients with a history of lymphedema